Guidelines for the screening and surveillance of Barrett’s esophagus continue to evolve as the incidence of esophageal adenocarcinoma increases, identification of individuals at highest risk for cancer improves, and management…
Barrett’s esophagus (BE) predisposes patients to esophageal adenocarcinoma. 3 to 6% of individuals with gastro-esophageal reflux disease are estimated to have BE but only 20 to 25% of BE patients…
Despite the availability of safe and effective endoscopic treatment of Barrett’s esophagus (BE)–related dysplasia and neoplasia, the incidence and mortality from esophageal adenocarcinoma (EAC) have continued to increase. This likely…
Barrett’s esophagus and esophageal adenocarcinoma diagnoses have increased markedly in recent decades. Recent research with patients diagnosed with Barrett’s esophagus (the only known precursor for esophageal adenocarcinoma) and esophageal adenocarcinoma…
Nicholas J. Shaheen, MD, MPH, Editor I am so pleased to introduce this issue of Gastrointestinal Endoscopy Clinics of North America , “New Directions in Barrett’s Esophagus.” In terms of…
Charles J. Lightdale, MD, Consulting Editor The incidence of esophageal adenocarcinoma has risen 10-fold in the United States since the 1970s and continues to rise at an alarming rate. While…
This article examines the transitions in pharmacological therapy for obesity. It reviews the current options approved by the Food and Drug Administration and several drugs approved for other indications that…
Obesity is associated with a spectrum of chronic liver disease. Because obesity increases the risk for advanced forms of liver disease (ie, cirrhosis and liver cancer), the obesity epidemic is…
Obesity is a risk factor for colorectal cancer and adenomatous polyps. The increased prevalence of neoplasia coupled with the observation that obesity may be associated with a suboptimal bowel preparation…
Obesity is a leading cause of illness and death worldwide. It is a risk factor for many common gastrointestinal symptoms and digestive disorders, including many cancers. Disruption of mechanisms that…
